The relationship between hemoglobin variability and oxidative stress and inflammation in CKD
暂无分享,去创建一个
[1] Connie M. Rhee,et al. Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis , 2017, American Journal of Nephrology.
[2] D. Gilbertson,et al. Variability in hemoglobin levels in hemodialysis patients in the current era: a retrospective cohort study , 2017, Clinical nephrology.
[3] W. Fang,et al. The role of hemoglobin variability as a prognostic indicator in peritoneal dialysis patients: a retrospective descriptive study , 2017, International Urology and Nephrology.
[4] Tetsuhiro Tanaka,et al. How the Target Hemoglobin of Renal Anemia Should Be? , 2015, Nephron.
[5] R. Foley,et al. Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] R. Foley,et al. Hemoglobin level variability: associations with mortality. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[7] M. Joffe,et al. Hemoglobin variability and mortality in ESRD. , 2007, Journal of the American Society of Nephrology : JASN.
[8] R. Foley,et al. Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[9] S. Greenland,et al. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. , 2006, Journal of the American Society of Nephrology : JASN.
[10] S. Fishbane,et al. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. , 2005, Kidney international.
[11] J. Lazarus,et al. Effect of variability in anemia management on hemoglobin outcomes in ESRD. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] P. Stenvinkel,et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] A. Hishida,et al. Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. , 2002, Kidney international.
[14] P. Stenvinkel,et al. Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] Z. Massy,et al. Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] B. Babior. The NADPH Oxidase of Endothelial Cells , 2000, IUBMB life.